Ion Cutelaba accepts 6-month USADA suspension for ozone therapy

March 8, 2018

Ion Cutelaba has been suspended 6 months by USADA after declaring the use of an alternative therapeutic treatment that is prohibited under certain routes of administration.

Via USADA release:

Cutelaba, 24, declared the use of ozone therapy on his doping control paperwork during out-of-competition tests conducted on October 18, 2017, and October 19, 2017. Ozone therapy is a treatment that can be administered in a variety of methods, some of which are prohibited under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.

Based on Cutelaba’s doping control paperwork, USADA contacted the athlete to request more information about the route of administration in order to establish whether the treatment was permissible. Cutelaba’s physician subsequently provided documentation indicating that the treatment was administered on October 3, 2017, and October 17, 2017, in a prohibited manner, as it involved a blood transfusion. The WADA Prohibited List prohibits the administration or reintroduction of blood or red blood cell products of any origin or quantity in the circulatory system, unless a valid Therapeutic Use Exemption has been obtained. While Cutelaba was unaware of the violation and declared the treatment on his doping control paperwork, he was unable to refute the documentation provided.

Under the UFC Anti-Doping Policy, as well as the World Anti-Doping Code, an athlete’s period of ineligibility for using a prohibited method may be reduced due to an individual’s voluntary admission of a violation and/or pursuant to an analysis of the athlete’s degree of fault for the anti-doping policy violation. Here, after taking both of those factors into consideration, USADA determined that a reduction to six-months from the standard two-year period of ineligibility was an appropriate sanction under the rules for Cutelaba’s violation.

Cutelaba’s six-month period of ineligibility began on November 3, 2017, the date he was provisionally suspended from competition. As a result of his violation, Cutelaba was previously removed from the Card for the UFC 217 event in New York City that was held on November 4, 2017.

Payout Perspective:

A modest suspension which ends in a couple months although it cost the 24-year-old a spot on UFC 217 in New York.  It’s clear that the blood transfusion given to Cutelaba was the primary issue and since there was not a TUE requested, there was a problem.  So, the issue is whether Cutelaba or his management knew the rules prior to the ozone therapy.

Got something to say?

You must be logged in to post a comment.